Jump to content

Julie Ann Sosa: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
Added tags to the page using Page Curation (coi)
Rte186 (talk | contribs)
Removed detailed research descriptions and added refs to awards
Line 15: Line 15:
Sosa leads the Duke Endocrine Neoplasia Diseases Group, a large transdisciplinary group of clinicians and researchers focused on improving clinical and economic outcomes for patients with [[endocrine disease]]s.<ref>{{Cite news|url=https://www.dcri.org/our-work/therapeutic-expertise/endocrine-neoplasia|title=Endocrine Neoplasia - DCRI|work=DCRI|access-date=2017-10-17|language=en-US}}</ref> The research team focuses on identifying ways to optimize patient clinical and economic outcomes following surgery and in the arena of thyroid, parathyroid, adrenal, and endocrine pancreas diseases. Sosa and her research team have made significant discoveries that have led to improved outcomes for patients with endocrine disease, including [[thyroid cancer]].
Sosa leads the Duke Endocrine Neoplasia Diseases Group, a large transdisciplinary group of clinicians and researchers focused on improving clinical and economic outcomes for patients with [[endocrine disease]]s.<ref>{{Cite news|url=https://www.dcri.org/our-work/therapeutic-expertise/endocrine-neoplasia|title=Endocrine Neoplasia - DCRI|work=DCRI|access-date=2017-10-17|language=en-US}}</ref> The research team focuses on identifying ways to optimize patient clinical and economic outcomes following surgery and in the arena of thyroid, parathyroid, adrenal, and endocrine pancreas diseases. Sosa and her research team have made significant discoveries that have led to improved outcomes for patients with endocrine disease, including [[thyroid cancer]].


== Professional Memberships and Awards ==
=== Epidemiology of Thyroid Cancer ===
In recognition for her scientific contributions, Sosa has been elected into professional societies and has been honored with awards over the years, a few of which are listed below:
Recently, she has studied the evolving epidemiology of thyroid cancer and potentially modifiable risk factors in the [[exposome]]. Work with collaborators at the [[National Cancer Institute]] described how the increasing incidence of thyroid cancer in the United States appears to be real and not just the result of overdiagnosis because thyroid tumors of all sizes and stages are increasing in frequency, as is incidence-based mortality.<ref>{{Cite journal|last=Lim|first=Hyeyeun|last2=Devesa|first2=Susan S.|last3=Sosa|first3=Julie A.|last4=Check|first4=David|last5=Kitahara|first5=Cari M.|date=2017-04-04|title=Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013|url=https://jamanetwork.com/journals/jama/fullarticle/2613728|journal=JAMA|language=en|volume=317|issue=13|doi=10.1001/jama.2017.2719|issn=0098-7484}}</ref><ref>{{Cite journal|last=Kitahara|first=Cari M.|last2=Sosa|first2=Julie A.|date=2016-07-15|title=The changing incidence of thyroid cancer|url=http://dx.doi.org/10.1038/nrendo.2016.110|journal=Nature Reviews Endocrinology|language=en|volume=12|issue=11|pages=646–653|doi=10.1038/nrendo.2016.110|issn=1759-5037}}</ref> A collaborative project with environmental scientists at the Nicholas School of the Environment at Duke University described a potential association between flame retardants in the home and the occurrence and severity of papillary thyroid cancer.<ref>{{Cite journal|last=Hoffman|first=Kate|last2=Lorenzo|first2=Amelia|last3=Butt|first3=Craig M.|last4=Hammel|first4=Stephanie C.|last5=Henderson|first5=Brittany Bohinc|last6=Roman|first6=Sanziana A.|last7=Scheri|first7=Randall P.|last8=Stapleton|first8=Heather M.|last9=Sosa|first9=Julie Ann|date=2017-10-01|title=Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: A case-control study|url=http://www.sciencedirect.com/science/article/pii/S0160412017306761|journal=Environment International|volume=107|issue=Supplement C|pages=235–242|doi=10.1016/j.envint.2017.06.021}}</ref>

=== Increasing Surgeon or Hospital Volume Improves Patient Outcomes Following Thyroidectomy and Pancreatectomy ===
Sosa was one of the first health services researchers in the United States to demonstrate a strong association between increasing surgeon or hospital volume and improved patient outcomes following thyroidectomy and pancreatectomy.<ref name=":1" /><ref name="Sosa 3058–3065">{{Cite journal|last=Sosa|first=Julie Ann|last2=Tuggle|first2=Charles T.|last3=Wang|first3=Tracy S.|last4=Thomas|first4=Daniel C.|last5=Boudourakis|first5=Leon|last6=Rivkees|first6=Scott|last7=Roman|first7=Sanziana A.|date=2008-08-01|title=Clinical and Economic Outcomes of Thyroid and Parathyroid Surgery in Children|url=https://academic.oup.com/jcem/article/93/8/3058/2598650/Clinical-and-Economic-Outcomes-of-Thyroid-and|journal=The Journal of Clinical Endocrinology & Metabolism|volume=93|issue=8|pages=3058–3065|doi=10.1210/jc.2008-0660|issn=0021-972X}}</ref><ref>{{Cite journal|last=Boudourakis|first=Leon D.|last2=Wang|first2=Tracy S.|last3=Roman|first3=Sanziana A.|last4=Desai|first4=Rani|last5=Sosa|first5=Julie A.|date=July 2009|title=Evolution of the surgeon-volume, patient-outcome relationship|url=https://www.ncbi.nlm.nih.gov/pubmed/19561457|journal=Annals of Surgery|volume=250|issue=1|pages=159–165|doi=10.1097/SLA.0b013e3181a77cb3|issn=1528-1140|pmid=19561457}}</ref> This finding subsequently has been replicated for an array of procedures and is used by payers and policymakers as a criterion for driving reimbursement and referral patterns. In 2016, Sosa and her team identified the volume-outcome threshold for thyroidectomy, and these recommendations are now being considered for reimbursement criteria.<ref>{{Cite journal|last=Adam|first=Mohamed Abdelgadir|last2=Thomas|first2=Samantha|last3=Youngwirth|first3=Linda|last4=Hyslop|first4=Terry|last5=Reed|first5=Shelby D.|last6=Scheri|first6=Randall P.|last7=Roman|first7=Sanziana A.|last8=Sosa|first8=Julie A.|date=2016-03-08|title=Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?|url=https://www.ncbi.nlm.nih.gov/pubmed/26967630|journal=Annals of Surgery|doi=10.1097/SLA.0000000000001688|issn=1528-1140|pmid=26967630}}</ref><ref>{{Cite news|url=https://well.blogs.nytimes.com/2016/03/16/choose-a-thyroid-surgeon-who-does-dozens-of-operations-a-year/?mcubz=1&mcubz=1|title=Choose a Thyroid Surgeon Who Does Dozens of Operations a Year|last=Bakalar|first=Nicholas|work=Well|access-date=2017-10-17|language=en}}</ref>

=== Disparities in Access to Care in Endocrine Surgery and Surgical Oncology ===
Sosa’s research team has focused on understanding disparities in access to care in [[endocrine surgery]] and [[surgical oncology]] based on patient demographic and clinical factors. They have described significant differences in patient clinical and economic outcomes based on age and race, as well as insurance status.<ref>{{Cite journal|last=Sosa|first=Julie Ann|last2=Mehta|first2=Pritesh J.|last3=Wang|first3=Tracy S.|last4=Yeo|first4=Heather L.|last5=Roman|first5=Sanziana A.|date=December 2007|title=Racial disparities in clinical and economic outcomes from thyroidectomy|url=https://www.ncbi.nlm.nih.gov/pubmed/18043114|journal=Annals of Surgery|volume=246|issue=6|pages=1083–1091|doi=10.1097/SLA.0b013e31812eecc4|issn=0003-4932|pmid=18043114}}</ref><ref name="Sosa 3058–3065"/><ref>{{Cite journal|last=Tuggle|first=Charles T.|last2=Park|first2=Lesley S.|last3=Roman|first3=Sanziana|last4=Udelsman|first4=Robert|last5=Sosa|first5=Julie Ann|date=2010-11-01|title=Rehospitalization among Elderly Patients with Thyroid Cancer after Thyroidectomy are Prevalent and Costly|url=https://link.springer.com/article/10.1245/s10434-010-1144-7|journal=Annals of Surgical Oncology|language=en|volume=17|issue=11|pages=2816–2823|doi=10.1245/s10434-010-1144-7|issn=1068-9265}}</ref> In addition, they have described how practice guidelines are less likely to be followed for these same patient sub-groups. They have shown that this, in turn, is associated with compromised survival.<ref>{{Cite journal|last=Adam|first=Mohamed Abdelgadir|last2=Goffredo|first2=Paolo|last3=Youngwirth|first3=Linda|last4=Scheri|first4=Randall P.|last5=Roman|first5=Sanziana A.|last6=Sosa|first6=Julie A.|date=January 2016|title=Same thyroid cancer, different national practice guidelines: When discordant American Thyroid Association and National Comprehensive Cancer Network surgery recommendations are associated with compromised patient outcome|url=https://www.ncbi.nlm.nih.gov/pubmed/26435426|journal=Surgery|volume=159|issue=1|pages=41–50|doi=10.1016/j.surg.2015.04.056|issn=1532-7361|pmid=26435426}}</ref>

=== Prospective Cohort Studies and Clinical Trials in Endocrine Neoplasia ===
Sosa has been involved in the design and management of clinical trials and prospective cohort studies in endocrine neoplasia. These have focused on developing novel drug therapies for advanced endocrine malignancies, as well as measuring the effect of parathyroid surgery on the psychiatric and neurocognitive disability associated with primary [[hyperparathyroidism]].<ref>{{Cite journal|last=Wells|first=Samuel A.|last2=Gosnell|first2=Jessica E.|last3=Gagel|first3=Robert F.|last4=Moley|first4=Jeffrey|last5=Pfister|first5=David|last6=Sosa|first6=Julie A.|last7=Skinner|first7=Michael|last8=Krebs|first8=Annetta|last9=Vasselli|first9=James|date=2010-02-10|title=Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834392/|journal=Journal of Clinical Oncology|volume=28|issue=5|pages=767–772|doi=10.1200/JCO.2009.23.6604|issn=0732-183X|pmc=2834392|pmid=20065189}}</ref><ref>{{Cite journal|last=Deshpande|first=Hari A|last2=Gettinger|first2=Scott|last3=Sosa|first3=Julie Ann|date=2009|title=Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2899774/|journal=Core evidence|volume=4|pages=43–48|issn=1555-1741|pmc=2899774|pmid=20694064}}</ref><ref>{{Cite journal|last=Roman|first=Sanziana A.|last2=Sosa|first2=Julie Ann|last3=Pietrzak|first3=Robert H.|last4=Snyder|first4=Peter J.|last5=Thomas|first5=Daniel C.|last6=Udelsman|first6=Robert|last7=Mayes|first7=Linda|date=January 2011|title=The effects of serum calcium and parathyroid hormone changes on psychological and cognitive function in patients undergoing parathyroidectomy for primary hyperparathyroidism|url=https://www.ncbi.nlm.nih.gov/pubmed/21233611|journal=Annals of Surgery|volume=253|issue=1|pages=131–137|doi=10.1097/SLA.0b013e3181f66720|issn=1528-1140|pmid=21233611}}</ref> Sosa has served as the international principal investigator for the largest therapeutic clinical trial performed for anaplastic thyroid cancer, and as a site principal investigator for a number of other trials focused on medullary and differentiated thyroid cancer, resulting in FDA approval of three drugs.<ref>{{Cite journal|last=Sosa|first=Julie A.|last2=Elisei|first2=Rossella|last3=Jarzab|first3=Barbara|last4=Balkissoon|first4=Jai|last5=Lu|first5=Shiao-Ping|last6=Bal|first6=Chandrasekhar|last7=Marur|first7=Shanthi|last8=Gramza|first8=Ann|last9=Yosef|first9=Rami Ben|date=February 2014|title=Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma|url=https://www.ncbi.nlm.nih.gov/pubmed/23721245|journal=Thyroid: Official Journal of the American Thyroid Association|volume=24|issue=2|pages=232–240|doi=10.1089/thy.2013.0078|issn=1557-9077|pmid=23721245}}</ref>

=== Guidelines to Standardize Practice Patterns for the Management of Endocrine Disease ===
Sosa’s research team has performed population-level analyses of nationally representative databases to standardize practice patterns for endocrine surgical procedures, including lymphadenectomy, and the management of hyperthyroidism, neuroendocrine tumors, thyroid nodules, and differentiated thyroid cancer. Their findings have been incorporated into the [[American Thyroid Association]] guidelines for thyroid nodules, differentiated thyroid cancer, and hyperthyroidism.<ref name=":2" /><ref>{{Cite journal|last=Robinson|first=Timothy J.|last2=Thomas|first2=Samantha|last3=Dinan|first3=Michaela A.|last4=Roman|first4=Sanziana|last5=Sosa|first5=Julie Ann|last6=Hyslop|first6=Terry|date=2016-09-27|title=How Many Lymph Nodes Are Enough? Assessing the Adequacy of Lymph Node Yield for Papillary Thyroid Cancer|url=http://ascopubs.org/doi/abs/10.1200/jco.2016.67.6437|journal=Journal of Clinical Oncology|volume=34|issue=28|pages=3434–3439|doi=10.1200/JCO.2016.67.6437|issn=0732-183X}}</ref><ref>{{Cite journal|last=Adam|first=Mohamed Abdelgadir|last2=Pura|first2=John|last3=Gu|first3=Lin|last4=Dinan|first4=Michaela A.|last5=Tyler|first5=Douglas S.|last6=Reed|first6=Shelby D.|last7=Roman|first7=Sanziana A.|last8=Sosa|first8=Julie A.|date=2014-10|title=Extent of Surgery for Papillary Thyroid Cancer Is Not Associated with Survival: An Analysis of 61,775 Patients|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4532384/|journal=Annals of Surgery|volume=260|issue=4|pages=601–607|doi=10.1097/SLA.0000000000000925|issn=0003-4932|pmc=4532384|pmid=25203876}}</ref><ref>{{Cite journal|last=Abdelgadir Adam|first=Mohamed|last2=Pura|first2=John|last3=Goffredo|first3=Paolo|last4=Dinan|first4=Michaela A.|last5=Hyslop|first5=Terry|last6=Reed|first6=Shelby D.|last7=Scheri|first7=Randall P.|last8=Roman|first8=Sanziana A.|last9=Sosa|first9=Julie A.|date=2015-1|title=Impact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 Years|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399499/|journal=The Journal of Clinical Endocrinology and Metabolism|volume=100|issue=1|pages=115–121|doi=10.1210/jc.2014-3039|issn=0021-972X|pmc=5399499|pmid=25337927}}</ref><ref>{{Cite journal|last=Ruel|first=Ewa|last2=Thomas|first2=Samantha|last3=Dinan|first3=Michaela|last4=Perkins|first4=Jennifer M.|last5=Roman|first5=Sanziana A.|last6=Sosa|first6=Julie Ann|date=April 2015|title=Adjuvant Radioactive Iodine Therapy Is Associated With Improved Survival for Patients With Intermediate-Risk Papillary Thyroid Cancer|url=http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399282/|journal=The Journal of Clinical Endocrinology and Metabolism|volume=100|issue=4|pages=1529–1536|doi=10.1210/jc.2014-4332|issn=0021-972X|pmc=4399282|pmid=25642591}}</ref><ref>{{Cite journal|last=Adam|first=Mohamed Abdelgadir|last2=Pura|first2=John|last3=Goffredo|first3=Paolo|last4=Dinan|first4=Michaela A.|last5=Reed|first5=Shelby D.|last6=Scheri|first6=Randall P.|last7=Hyslop|first7=Terry|last8=Roman|first8=Sanziana A.|last9=Sosa|first9=Julie A.|date=2015-07-20|title=Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer|url=http://ascopubs.org/doi/abs/10.1200/JCO.2014.59.8391|journal=Journal of Clinical Oncology|volume=33|issue=21|pages=2370–2375|doi=10.1200/JCO.2014.59.8391|issn=0732-183X}}</ref><ref>{{Cite web|url=https://corporate.dukehealth.org/news-listing/lymph-nodes-signal-more-aggressive-thyroid-cancer-even-young-patients|title=Lymph Nodes Signal More Aggressive Thyroid Cancer Even in Young Patients {{!}} Duke Health|website=corporate.dukehealth.org|language=en|access-date=2017-10-17}}</ref><ref>{{Cite journal|last=Haugen|first=Bryan R.|last2=Alexander|first2=Erik K.|last3=Bible|first3=Keith C.|last4=Doherty|first4=Gerard M.|last5=Mandel|first5=Susan J.|last6=Nikiforov|first6=Yuri E.|last7=Pacini|first7=Furio|last8=Randolph|first8=Gregory W.|last9=Sawka|first9=Anna M.|date=2016-01-01|title=2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4739132/|journal=Thyroid|language=en|volume=26|issue=1|pages=1|doi=10.1089/thy.2015.0020|pmid=26462967}}</ref>

=== Understanding Attrition Rates from General Surgery Residency Training Programs ===
Sosa’s team worked with the [[American Board of Surgery]] to perform a national prospective study of three cohorts of general surgery trainees across the United States to elucidate the factors contributing to high attrition rates in general surgery residency programs. This National Study of Expectations and Attitudes of Residents in Surgery (NEARS) identified several factors associated with increased risk of attrition, and their findings have been incorporated into ongoing residency program reform efforts.<ref>{{Cite journal|last=Yeo|first=Heather|last2=Viola|first2=Kate|last3=Berg|first3=David|last4=Lin|first4=Zhenqiu|last5=Nunez-Smith|first5=Marcella|last6=Cammann|first6=Cortland|last7=Bell|first7=Richard H.|last8=Sosa|first8=Julie Ann|last9=Krumholz|first9=Harlan M.|date=2009-09-23|title=Attitudes, Training Experiences, and Professional Expectations of US General Surgery Residents|url=https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2009.1386|journal=JAMA|language=en|volume=302|issue=12|doi=10.1001/jama.2009.1386|issn=0098-7484}}</ref><ref>{{Cite journal|last=Bucholz|first=Emily M.|date=2011-08-15|title=Our Trainees’ Confidence|url=https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/archsurg.2011.178|journal=Archives of Surgery|language=en|volume=146|issue=8|doi=10.1001/archsurg.2011.178|issn=0004-0010}}</ref><ref>{{Cite journal|last=Sullivan|first=Michael C.|last2=Yeo|first2=Heather|last3=Roman|first3=Sanziana A.|last4=Bell|first4=Richard H.|last5=Sosa|first5=Julie A.|date=March 2013|title=Striving for work-life balance: effect of marriage and children on the experience of 4402 US general surgery residents|url=https://www.ncbi.nlm.nih.gov/pubmed/22964726|journal=Annals of Surgery|volume=257|issue=3|pages=571–576|doi=10.1097/SLA.0b013e318269d05c|issn=1528-1140|pmid=22964726}}</ref><ref>{{Cite journal|last=Wong|first=Risa L.|last2=Sullivan|first2=Michael C.|last3=Yeo|first3=Heather L.|last4=Roman|first4=Sanziana A.|last5=Bell|first5=Richard H.|last6=Sosa|first6=Julie A.|date=April 2013|title=Race and surgical residency: results from a national survey of 4339 US general surgery residents|url=https://www.ncbi.nlm.nih.gov/pubmed/23001076|journal=Annals of Surgery|volume=257|issue=4|pages=782–787|doi=10.1097/SLA.0b013e318269d2d0|issn=1528-1140|pmid=23001076}}</ref><ref>{{Cite journal|last=Yeo|first=Heather L.|last2=Abelson|first2=Jonathan S.|last3=Mao|first3=Jialin|last4=Lewis|first4=Frank|last5=Michelassi|first5=Fabrizio|last6=Bell|first6=Richard|last7=Sedrakyan|first7=Art|last8=Sosa|first8=Julie A.|date=September 2017|title=Who Makes It to the End?: A Novel Predictive Model for Identifying Surgical Residents at Risk for Attrition|url=http://journals.lww.com/annalsofsurgery/Abstract/2017/09000/Who_Makes_It_to_the_End___A_Novel_Predictive_Model.13.aspx|journal=Annals of Surgery|volume=266|issue=3|pages=499–507|doi=10.1097/SLA.0000000000002384|issn=0003-4932}}</ref>

== Accolades and awards ==
Sosa has received many awards and professional memberships for her scientific contributions, a few of which are listed below:


=== Societies ===
=== Societies ===
* Elected Member of the American Surgical Association<ref>{{Cite web|url=http://americansurgical.org/newsletter/2014-Summer-full.cgi|title=ASA Newsletter: Summer 2014 newsletter|website=americansurgical.org|access-date=2017-12-20}}</ref>
* American Surgical Association
* Member of the Association for Academic Surgery<ref>{{Cite news|url=https://www.aasurg.org/leadership|title=Leadership - Association for Academic Surgery|work=Association for Academic Surgery|access-date=2017-12-20|language=en-US}}</ref>
* Association for Academic Surgery
* Executive Council Member of the Society of Surgical Oncology<ref>{{Cite web|url=http://www.surgonc.org/about-sso/leadership/executive-council|title=Executive Council|website=www.surgonc.org|access-date=2017-12-20}}</ref>
* Society of Surgical Oncology
* Treasurer of the American Thyroid Association<ref>{{Cite web|url=https://surgery.duke.edu/news/dr-julie-ann-sosa-elected-treasurer-american-thyroid-association|title=Dr. Julie Ann Sosa Elected Treasurer of the American Thyroid Association {{!}} Duke Department of Surgery|website=surgery.duke.edu|language=en|access-date=2017-12-20}}</ref>
* American Thyroid Association
* Elected Member of the American Association of Endocrine Surgeons<ref>{{Cite web|url=http://endocrinesurgery.org/About-Us/Governance/Committees|title=The American Association of Endocrine Surgeons > About Us > Governance > Committees|website=endocrinesurgery.org|language=en-US|access-date=2017-12-20}}</ref>
* American Association of Endocrine Surgeons
* Board Member of the International Thyroid Oncology Group<ref>{{Cite web|url=http://www.itog.org/leadership|title=Leadership {{!}} International Thyroid Oncology Group|website=www.itog.org|language=en|access-date=2017-12-20}}</ref>
* Society of University Surgeons
* Committee Member of the National Comprehensive Cancer Network (NCCN) Guidelines for Treatment of Neuroendocrine Tumors<ref name=":0" />
* International Thyroid Oncology Group
* Elected Member of the Society of Clinical Surgery<ref>{{Cite web|url=http://www.societyofclinicalsurgery.com/members|title=Active Members - Society of Clinical Surgery|website=www.societyofclinicalsurgery.com|access-date=2017-12-20}}</ref>
* National Comprehensive Cancer Network (NCCN) Guidelines Panel for Treatment of Neuroendocrine Tumors
* Elected Member of the Halsted Society<ref>{{Cite news|url=http://www.halstedsociety.com/2017_program_8-22-17.pdf|title=Halsted Society|last=|first=|date=|work=|access-date=12/20/17|archive-url=|archive-date=|dead-url=}}</ref>
* Society of Clinical Surgery
* Endocrine Expert Panel, American Joint Committee on Cancer (AJCC) Cancer Staging System, 8th Edition
* The Endocrine Society
* Halsted Society


=== Honors ===
=== Honors ===
* Research Career Development Award, Claude D. Pepper Center at Yale<ref>{{Cite web|url=https://medicine.yale.edu/intmed/geriatrics/news/article.aspx?id=4010|title=Pepper Center Awards Support Research Related to Aging > Geriatrics {{!}} Internal Medicine {{!}} Yale School of Medicine|website=medicine.yale.edu|language=en|access-date=2017-12-20}}</ref>
* John G Haddad Award, The Paget Foundation
* JJ Roslyn Faculty Research Award, Association for Academic Surgery<ref>{{Cite news|url=https://www.aasurg.org/awards/roslyn-faculty-award|title=Roslyn Faculty Award - Association for Academic Surgery|work=Association for Academic Surgery|access-date=2017-12-20|language=en-US}}</ref>
* Research Career Development Award, Claude D. Pepper Center at Yale
* Association for Academic Surgery International Visiting Professorship Award<ref>{{Cite news|url=https://www.aasurg.org/awards/travel-grants-visiting-professorships|title=Travel Grants & Visiting Professorships - Association for Academic Surgery|work=Association for Academic Surgery|access-date=2017-12-20|language=en-US}}</ref>
* JJ Roslyn Faculty Research Award, Association for Academic Surgery
* Johns Hopkins Society of Scholars, Johns Hopkins University<ref>{{Cite news|url=https://hub.jhu.edu/gazette/2014/may-june/workplace-society-of-scholars-inducted|title=Society of Scholars inducts new members|date=2014-05-06|work=The Hub|access-date=2017-12-20|language=en}}</ref>
* Dennis Jahnigen Career Development Award, American Geriatrics Association
* Distinguished Alumna Award, Johns Hopkins University<ref>{{Cite web|url=https://alumni.jhu.edu/distinguishedalumni2014|title=Distinguished Alumnus Award 2014 {{!}} Johns Hopkins Alumni|website=alumni.jhu.edu|language=en|access-date=2017-12-20}}</ref>
* Association for Academic Surgery International Visiting Professorship Award (AAS/RACS)
* Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Class of 2016<ref>{{Cite web|url=https://medschool.duke.edu/about-us/news-and-communications/med-school-blog/elam-names-julie-ann-sosa-md-2015-2016-class-fellows|title=ELAM Names Julie Ann Sosa, MD to 2015-2016 Class of Fellows {{!}} Duke School of Medicine|website=medschool.duke.edu|language=en|access-date=2017-12-20}}</ref>
* Johns Hopkins Society of Scholars, Johns Hopkins University
* Woman of the Year in Thyroidology 2017, American Thyroid Association<ref>{{Cite web|url=https://www.thyroid.org/thyroid-association-membership/women-in-thyroidology|title=Women in Thyroidology {{!}} American Thyroid Association|website=www.thyroid.org|language=en-US|access-date=2017-12-20}}</ref>
* Distinguished Alumna Award, Johns Hopkins University
* Lewis E. Braverman Distinguished Lectureship Award, American Thyroid Association, 2017<ref>{{Cite web|url=https://www.thyroid.org/distinguished-lectureship-recipient|title=ATA selects Lewis E. Braverman Distinguished Lectureship Award recipient {{!}} American Thyroid Association|website=www.thyroid.org|language=en-US|access-date=2017-12-20}}</ref>
* Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Class of 2016
* PO Granberg Lecturer, Swedish Society for Endocrine Surgeons
* Invited International Visitor, Younger Fellows Section, Royal Australasian College of Surgeons
* Woman of the Year in Thyroidology 2017, American Thyroid Association
* Lewis E. Braverman Distinguished Lectureship Award, American Thyroid Association, 2017


== References ==
== References ==

Revision as of 21:13, 20 December 2017

Julie Ann Sosa, MD, MA, FACS, is Chief of Endocrine Surgery and Director of the Surgical Center for Outcomes Research in the Department of Surgery at the Duke University School of Medicine.[1] Sosa leads the Duke Endocrine Neoplasia Diseases Group and is Co-Leader of the Solid Tumor Therapeutics Program at the Duke Cancer Institute and the Duke Clinical Research Institute.[2][3] She currently serves as the Treasurer of the American Thyroid Association and will serve as Editor-in-Chief of the World Journal of Surgery in January 2018.

Sosa is an American endocrine surgeon and surgical oncologist, specializing in thyroid cancer.[4] She is internationally recognized for her work in health services research, demonstrating for the first time in the United States a strong association between a higher surgeon or hospital case volume and improved patient outcomes following thyroidectomy and pancreatectomy,[5] as well as optimal extent of thyroid surgery and lymphadenectomy for thyroid cancer. Her contributions have led to the revision of practice guidelines for the management of patients with endocrine diseases.[6]

Education and Previous Appointments

Sosa received her medical degree from Johns Hopkins University School of Medicine in 1994 and went on to complete the Halsted Residency in Surgery at Johns Hopkins in 2001, followed by a fellowship in Surgical Oncology as Assistant Chief of Service in 2002.[1] She was a Robert Wood Johnson Clinical Scholar from 1996–1998.

In 2002, Sosa joined the Yale School of Medicine as an Assistant Professor of Surgery, reaching the rank of Associate Professor in 2008. While at Yale, Sosa led the Clinical Research Program in Endocrine Cancers at Smilow Cancer Hospital at Yale New Haven. In 2012, Sosa joined the Duke University School of Medicine as Professor of Surgery and Medicine (Oncology).

Scientific Contributions

Sosa leads the Duke Endocrine Neoplasia Diseases Group, a large transdisciplinary group of clinicians and researchers focused on improving clinical and economic outcomes for patients with endocrine diseases.[7] The research team focuses on identifying ways to optimize patient clinical and economic outcomes following surgery and in the arena of thyroid, parathyroid, adrenal, and endocrine pancreas diseases. Sosa and her research team have made significant discoveries that have led to improved outcomes for patients with endocrine disease, including thyroid cancer.

Professional Memberships and Awards

In recognition for her scientific contributions, Sosa has been elected into professional societies and has been honored with awards over the years, a few of which are listed below:

Societies

  • Elected Member of the American Surgical Association[8]
  • Member of the Association for Academic Surgery[9]
  • Executive Council Member of the Society of Surgical Oncology[10]
  • Treasurer of the American Thyroid Association[11]
  • Elected Member of the American Association of Endocrine Surgeons[12]
  • Board Member of the International Thyroid Oncology Group[13]
  • Committee Member of the National Comprehensive Cancer Network (NCCN) Guidelines for Treatment of Neuroendocrine Tumors[1]
  • Elected Member of the Society of Clinical Surgery[14]
  • Elected Member of the Halsted Society[15]

Honors

  • Research Career Development Award, Claude D. Pepper Center at Yale[16]
  • JJ Roslyn Faculty Research Award, Association for Academic Surgery[17]
  • Association for Academic Surgery International Visiting Professorship Award[18]
  • Johns Hopkins Society of Scholars, Johns Hopkins University[19]
  • Distinguished Alumna Award, Johns Hopkins University[20]
  • Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Class of 2016[21]
  • Woman of the Year in Thyroidology 2017, American Thyroid Association[22]
  • Lewis E. Braverman Distinguished Lectureship Award, American Thyroid Association, 2017[23]

References

  1. ^ a b c "Julie Ann Sosa, MD | Duke Department of Surgery". surgery.duke.edu. Retrieved 2017-10-17.
  2. ^ "Julie Ann Sosa - DCRI". DCRI. Retrieved 2017-10-17.
  3. ^ "Meet new DCRI faculty member Julie Ann Sosa, MD - DCRI". DCRI. 2013-02-25. Retrieved 2017-10-17.
  4. ^ "Julie A. Sosa, MD, MA". Duke Health. Retrieved 2017-10-17.
  5. ^ Sosa, J A; Bowman, H M; Tielsch, J M; Powe, N R; Gordon, T A; Udelsman, R (September 1998). "The importance of surgeon experience for clinical and economic outcomes from thyroidectomy". Annals of Surgery. 228 (3): 320–330. ISSN 0003-4932. PMC 1191485. PMID 9742915.
  6. ^ Ross, Douglas S.; Burch, Henry B.; Cooper, David S.; Greenlee, M. Carol; Laurberg, Peter; Maia, Ana Luiza; Rivkees, Scott A.; Samuels, Mary; Sosa, Julie Ann (2016-08-12). "2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis". Thyroid. 26 (10): 1343–1421. doi:10.1089/thy.2016.0229. ISSN 1050-7256.
  7. ^ "Endocrine Neoplasia - DCRI". DCRI. Retrieved 2017-10-17.
  8. ^ "ASA Newsletter: Summer 2014 newsletter". americansurgical.org. Retrieved 2017-12-20.
  9. ^ "Leadership - Association for Academic Surgery". Association for Academic Surgery. Retrieved 2017-12-20.
  10. ^ "Executive Council". www.surgonc.org. Retrieved 2017-12-20.
  11. ^ "Dr. Julie Ann Sosa Elected Treasurer of the American Thyroid Association | Duke Department of Surgery". surgery.duke.edu. Retrieved 2017-12-20.
  12. ^ "The American Association of Endocrine Surgeons > About Us > Governance > Committees". endocrinesurgery.org. Retrieved 2017-12-20.
  13. ^ "Leadership | International Thyroid Oncology Group". www.itog.org. Retrieved 2017-12-20.
  14. ^ "Active Members - Society of Clinical Surgery". www.societyofclinicalsurgery.com. Retrieved 2017-12-20.
  15. ^ "Halsted Society" (PDF). Retrieved 12/20/17. {{cite news}}: Check date values in: |access-date= (help); Cite has empty unknown parameter: |dead-url= (help)
  16. ^ "Pepper Center Awards Support Research Related to Aging > Geriatrics | Internal Medicine | Yale School of Medicine". medicine.yale.edu. Retrieved 2017-12-20.
  17. ^ "Roslyn Faculty Award - Association for Academic Surgery". Association for Academic Surgery. Retrieved 2017-12-20.
  18. ^ "Travel Grants & Visiting Professorships - Association for Academic Surgery". Association for Academic Surgery. Retrieved 2017-12-20.
  19. ^ "Society of Scholars inducts new members". The Hub. 2014-05-06. Retrieved 2017-12-20.
  20. ^ "Distinguished Alumnus Award 2014 | Johns Hopkins Alumni". alumni.jhu.edu. Retrieved 2017-12-20.
  21. ^ "ELAM Names Julie Ann Sosa, MD to 2015-2016 Class of Fellows | Duke School of Medicine". medschool.duke.edu. Retrieved 2017-12-20.
  22. ^ "Women in Thyroidology | American Thyroid Association". www.thyroid.org. Retrieved 2017-12-20.
  23. ^ "ATA selects Lewis E. Braverman Distinguished Lectureship Award recipient | American Thyroid Association". www.thyroid.org. Retrieved 2017-12-20.